IT1270260B - Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi - Google Patents

Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi

Info

Publication number
IT1270260B
IT1270260B ITMI941291A ITMI941291A IT1270260B IT 1270260 B IT1270260 B IT 1270260B IT MI941291 A ITMI941291 A IT MI941291A IT MI941291 A ITMI941291 A IT MI941291A IT 1270260 B IT1270260 B IT 1270260B
Authority
IT
Italy
Prior art keywords
metallopeptidase
acid derivatives
phosphonic acid
inhibitive
activities
Prior art date
Application number
ITMI941291A
Other languages
English (en)
Inventor
Gabriele Norcini
Daniela Botta
Francesco Santangelo
Gabriele Morazzoni
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of ITMI941291A0 publication Critical patent/ITMI941291A0/it
Priority to ITMI941291A priority Critical patent/IT1270260B/it
Priority to DE69503904T priority patent/DE69503904T2/de
Priority to JP8501655A priority patent/JPH10501546A/ja
Priority to EP95924260A priority patent/EP0766687B1/en
Priority to US08/750,035 priority patent/US5739123A/en
Priority to AT95924260T priority patent/ATE169301T1/de
Priority to PCT/EP1995/002343 priority patent/WO1995035302A1/en
Priority to SI9520067A priority patent/SI9520067A/sl
Priority to AU28842/95A priority patent/AU2884295A/en
Priority to ES95924260T priority patent/ES2122646T3/es
Publication of ITMI941291A1 publication Critical patent/ITMI941291A1/it
Application granted granted Critical
Publication of IT1270260B publication Critical patent/IT1270260B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Vengono descritti composti di formula (FORMULA I) in cui R. R1, R2, m ed X hamo i significati riportati nella descrizione.I composti di formula I sono dotati di attività mista ACE - inibitrice e NEP - inibitrice e sono utili nel trattamento di disturbi cardiovascolari.
ITMI941291A 1994-06-21 1994-06-21 Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi IT1270260B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI941291A IT1270260B (it) 1994-06-21 1994-06-21 Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
US08/750,035 US5739123A (en) 1994-06-21 1995-06-16 Phosphinic acid derivatives with metallopeptidase inhibitory activity
JP8501655A JPH10501546A (ja) 1994-06-21 1995-06-16 メタロペプチダーゼ阻害作用を有するホスフィン酸誘導体
EP95924260A EP0766687B1 (en) 1994-06-21 1995-06-16 Phosphinic acid derivatives with metallopeptidase inhibitory activity
DE69503904T DE69503904T2 (de) 1994-06-21 1995-06-16 Phosphinsaeurederivate mit metallopeptidase inhibtorischer wirkung
AT95924260T ATE169301T1 (de) 1994-06-21 1995-06-16 Phosphinsaeurederivate mit metallopeptidase inhibtorischer wirkung
PCT/EP1995/002343 WO1995035302A1 (en) 1994-06-21 1995-06-16 Phosphinic acid derivatives with metallopeptidase inhibitory activity
SI9520067A SI9520067A (en) 1994-06-21 1995-06-16 Phosphinic acid derivates with metallopeptidase inhibitory activity.
AU28842/95A AU2884295A (en) 1994-06-21 1995-06-16 Phosphinic acid derivatives with metallopeptidase inhibitory activity
ES95924260T ES2122646T3 (es) 1994-06-21 1995-06-16 Derivados de acido fosfinico con actividad inhibidora de la metalopeptidasa.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941291A IT1270260B (it) 1994-06-21 1994-06-21 Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi

Publications (3)

Publication Number Publication Date
ITMI941291A0 ITMI941291A0 (it) 1994-06-21
ITMI941291A1 ITMI941291A1 (it) 1995-12-21
IT1270260B true IT1270260B (it) 1997-04-29

Family

ID=11369146

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI941291A IT1270260B (it) 1994-06-21 1994-06-21 Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi

Country Status (10)

Country Link
US (1) US5739123A (it)
EP (1) EP0766687B1 (it)
JP (1) JPH10501546A (it)
AT (1) ATE169301T1 (it)
AU (1) AU2884295A (it)
DE (1) DE69503904T2 (it)
ES (1) ES2122646T3 (it)
IT (1) IT1270260B (it)
SI (1) SI9520067A (it)
WO (1) WO1995035302A1 (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276710B1 (it) * 1995-06-14 1997-11-03 Zambon Spa Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi
FR2755135B1 (fr) * 1996-10-25 2002-12-27 Inst Nat Sante Rech Med Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent
FR2777780B1 (fr) 1998-04-22 2001-05-04 Inst Nat Sante Rech Med Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent
US6528499B1 (en) * 2000-04-27 2003-03-04 Georgetown University Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
CA2669127C (en) 2006-11-08 2016-09-13 Molecular Insight Pharmaceuticals, Inc. Heterodimers of glutamic acid
US8562945B2 (en) 2008-01-09 2013-10-22 Molecular Insight Pharmaceuticals, Inc. Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
FR2934267B1 (fr) * 2008-07-23 2010-08-13 Pharmaleads Derives aminophosphiniques utiles dans le traitement de la douleur
DE102008055916A1 (de) * 2008-11-05 2010-05-06 Clariant International Limited Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Allylalkoholen und ihre Verwendung
EP2346885B1 (de) * 2008-11-05 2013-08-28 Clariant International Ltd. Verfahren zur herstellung von monocarboxyfunktionaslisierten dialkylphosphinsäuren, -estern und -salzen mittels allylalkoholen/acroleinen und ihre verwendung
DE102008055914A1 (de) * 2008-11-05 2010-05-06 Clariant International Limited Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acroleinen und ihre Verwendung
DE102008056341A1 (de) * 2008-11-07 2010-05-12 Clariant International Limited Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung
ES2525550T3 (es) * 2008-11-07 2014-12-26 Clariant Finance (Bvi) Limited Procedimiento para la preparación de ácidos, ésteres y sales dialquilfosfínicos mediante derivados del ácido acrílico y su uso
DE102008056339A1 (de) * 2008-11-07 2010-05-12 Clariant International Limited Verfahren zur Herstellung von mono-aminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung
DE102008056342A1 (de) * 2008-11-07 2010-05-12 Clariant International Limited Verfahren zur Herstellung von Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung
JP5743219B2 (ja) 2008-11-11 2015-07-01 クラリアント・ファイナンス・（ビーブイアイ）・リミテッド アリル化合物を用いる、モノアリル官能性ジアルキルホスフィン酸、それらの塩およびエステルの製造方法およびそれらの使用
DE102008060035A1 (de) * 2008-12-02 2010-06-10 Clariant International Limited Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung
DE102008060036A1 (de) * 2008-12-02 2010-06-10 Clariant International Limited Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung
DE102008060535A1 (de) * 2008-12-04 2010-06-10 Clariant International Limited Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylether und ihre Verwendung
DE102008063642A1 (de) 2008-12-18 2010-06-24 Clariant International Limited Verfahren zur Herstellung von monocarboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Alkylenoxiden und ihre Verwendung
DE102008063627A1 (de) 2008-12-18 2010-06-24 Clariant International Limited Verfahren zur Herstellung von monohydroxyfunktionalisierten Dialkylphosphinsäuren,-estern und -salzen mittels Ethylenoxid und ihre Verwendung
JP5619769B2 (ja) 2008-12-18 2014-11-05 クラリアント・ファイナンス・（ビーブイアイ）・リミテッド アセチレンを利用したエチレンジアルキルホスフィン酸、エチレンジアルキルホスフィン酸エステル、およびエチレンジアルキルホスフィン酸塩の製造方法、およびそれらの使用
DE102008063668A1 (de) 2008-12-18 2010-07-01 Clariant International Limited Verfahren zur Herstellung von Alkylphosponsäuren, -estern und -salzen mittels Oxidation von Alkylphosphonigsäuren und ihre Verwendung
DE102008064003A1 (de) 2008-12-19 2010-06-24 Clariant International Limited Verfahren zur Herstellung von mono-funktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung
DE102008064012A1 (de) 2008-12-19 2010-06-24 Clariant International Limited Halogenfreie Addukte von Alkylphosphonigsäurederivaten und diesterbildenden Olefinen, halogenfreie Verfahren zu deren Herstellung und ihre Verwendung
BR112012000209B8 (pt) 2009-06-15 2021-07-27 Molecular Insight Pharm Inc heterodímeros de ácido glutâmico e seus processos de preparação
EP2800471A4 (en) 2012-01-06 2015-11-04 Molecular Insight Pharm Inc METAL COMPLEX OF POLY (CARBOXYL) AMINE CONTAINING LIGANDS HAVING AFFINITY FOR CARBON IX ANHYDRASE
CA2897437C (en) 2013-01-14 2021-12-14 Molecular Insight Pharmaceuticals, Inc. Triazine based radiopharmaceuticals and radioimaging agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379146A (en) * 1981-02-17 1983-04-05 Merck & Co., Inc. Substituted phosphonamides as antihypertensives
US4432972A (en) * 1981-08-03 1984-02-21 E. R. Squibb & Sons, Inc. Phosphonamidate compounds
US4396772A (en) * 1981-11-23 1983-08-02 F. R. Squibb & Sons, Inc. Phosphinylalkanoyl amino acids
DE3600365A1 (de) * 1986-01-09 1987-07-16 Hoechst Ag Neue thyroninderivate
IT1224405B (it) * 1987-12-23 1990-10-04 Simes Composti attivi sul sistema cardiovascolare
US5155100A (en) * 1991-05-01 1992-10-13 Ciba-Geigy Corporation Phosphono/biaryl substituted dipeptide derivatives
US5250522A (en) * 1992-10-09 1993-10-05 Ciba-Geigy Corporation Phosphono/biaryl substituted amino acid derivatives
WO1993014112A1 (en) * 1992-01-15 1993-07-22 Merck & Co., Inc. Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
IT1254521B (it) * 1992-03-17 1995-09-25 Zambon Spa Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare

Also Published As

Publication number Publication date
SI9520067A (en) 1997-10-31
US5739123A (en) 1998-04-14
DE69503904D1 (de) 1998-09-10
ES2122646T3 (es) 1998-12-16
ITMI941291A0 (it) 1994-06-21
EP0766687A1 (en) 1997-04-09
DE69503904T2 (de) 1999-04-22
WO1995035302A1 (en) 1995-12-28
AU2884295A (en) 1996-01-15
ITMI941291A1 (it) 1995-12-21
EP0766687B1 (en) 1998-08-05
ATE169301T1 (de) 1998-08-15
JPH10501546A (ja) 1998-02-10

Similar Documents

Publication Publication Date Title
BG103413A (en) Derivatives of sulphinic acid, their production and application
BG103964A (en) SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
DE59409880D1 (de) Methylphosphonsäureester, verfahren zu deren herstellung und deren verwendung
DE59807405D1 (de) Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
DE69919398D1 (de) 1,1,1,3,3-pentafluorbutan enthaltende zusammensetzungen und deren verwendung
MY121294A (en) Novel hexanoic acid derivatives.
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
TR199800608A2 (en) Propanolamin t�revleri, bunlar�n �retim usul�.
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
MY131693A (en) Arylacetic acid derivatives
MX9709910A (es) Compuestos que contienen arginina e imitaciones de arginina, su uso y composiciones que los contienen.
CA2094806A1 (en) Aminosulfonyl urea acat inhibitors
MX9700807A (es) Derivados de 3-azabiciclo (3.2.0)heptano n-sustituidos utiles como neurolepticos.
ATE211482T1 (de) Selektive inhibitoren des faktors x, eine azepinonstruktur enthaltend
SE9604582D0 (sv) Novel compounds
IT1270261B (it) Derivati peptidici ad attivita' inibitrice delle metallopeptidasi
ITMI931723A1 (it) Derivati della beta-mercapto-propanammide utili nel trattamento delle malattie cardiovascolari
DE69418110D1 (de) N-Heteroaryl substituierte Propanamid-Derivate brauchbar zur Behandlung cardiovascularer Krankheiten
IT1255471B (it) Derivati di catecolammine,processo per la loro preparazione e composizioni farmaceutiche che li contengono
IL141009A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof
HU9600300D0 (en) Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these
DE69614508D1 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970825